Who
A. J. Kazimi
Chairman and CEO
Company insider
Files Form 4 as: Chairman and CEO, Cumberland Pharmaceuticals.
In numbers
- Trades disclosed
- 968
- Buys
- 471
- Sells
- 1
- Bought
- $172K
- Sold
- $100K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 31 Dec 2009
- Last trade
- 18 Mar 2026
- Last filed
- 20 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Mar 2026filed 20 Mar 2026 | CPIX Cumberland Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $280K100,000 at $2.80 | filing |
| 18 Mar 2026filed 20 Mar 2026 | CPIX Cumberland Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $280K100,000 at $2.80 | filing |
| 16 Mar 2026filed 18 Mar 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $18K5,845 at $3.06 | filing |
| 16 Mar 2026filed 18 Mar 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $18K5,845 at $3.06 | filing |
| 31 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $277 at $3.91 | filing |
| 31 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $277 at $3.91 | filing |
| 30 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $328 at $3.94 | filing |
| 30 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $328 at $3.94 | filing |
| 29 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $328 at $4.01 | filing |
| 29 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $328 at $4.01 | filing |
| 26 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $348 at $4.21 | filing |
| 26 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $348 at $4.21 | filing |
| 24 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $348 at $4.26 | filing |
| 24 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $348 at $4.26 | filing |
| 23 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $338 at $4.13 | filing |
| 23 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $338 at $4.13 | filing |
| 22 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $307 at $4.32 | filing |
| 22 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $307 at $4.32 | filing |
| 19 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $348 at $4.19 | filing |
| 19 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $348 at $4.19 | filing |
The newest 500 lines are listed; the numbers count every line.
News
CUMBERLAND PHARMACEUTICALS ANNOUNCES NATIONAL CALL TO PRESENT AN UPDATE ON ITS IFETROBAN DMD PROGRAMCPIX · prnewswire.com · 19 Oct 2026Head to Head Review: Cumberland Pharmaceuticals (NASDAQ:CPIX) & Eloxx Pharmaceuticals (NASDAQ:ELOX)CPIX · dailypolitical.com · 17 Oct 2026Contrasting Lifecore Biomedical (NASDAQ:LFCR) & Cumberland Pharmaceuticals (NASDAQ:CPIX)CPIX · tickerreport.com · 13 Oct 2026
0 headlines in the last 90 days name A. J. Kazimi; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.